Antimicrobial Peptides and Bacteriophages as Next-Generation Alternatives to Conventional Antibiotics

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume :02 | Issue : 01 | Page : 9-27
    By

    Sudipta Roy,

  1. Associate Professor, Bengal College of Pharmaceutical Technology, Dubrajpur, India

Abstract

The growing threat of antibiotic-resistant bacteria has underscored the urgent need for innovative alternatives to conventional antibiotics. Antimicrobial peptides (AMPs) and bacteriophages are gaining recognition as next-generation therapeutics due to their distinct mechanisms of action and ability to target resistant pathogens effectively. AMPs, which can be natural or synthetic, disrupt microbial membranes and offer broad-spectrum antimicrobial activity with a reduced likelihood of resistance development. Bacteriophages, as bacteria-specific viruses, provide precise targeting of pathogens while preserving beneficial microbiota and possess the ability to co-evolve with bacterial resistance mechanisms. These approaches hold significant promise for treating challenging infections, including those involving biofilms and multidrug-resistant bacteria. Furthermore, phage therapy can complement traditional antibiotics, potentially reducing the overuse of antibiotics and mitigating the rise of resistance. Additionally, phage cocktails, which combine multiple bacteriophages, enhance the effectiveness and reduce the likelihood of bacterial resistance development, offering a versatile and adaptive therapeutic strategy. However, obstacles such as ensuring stability, efficient delivery, and navigating regulatory requirements persist. Advances in formulation technologies, including encapsulation and nanotechnology, are paving the way for improved efficacy and clinical implementation. This abstract highlights AMPs and bacteriophages as innovative and sustainable strategies to combat the escalating crisis of antibiotic resistance.

Keywords: Antimicrobial Peptides, Bacteriophages, Antimicrobial Resistance, Novel Formulations for Antimicrobial Peptides, Biofilms

[This article belongs to International Journal of Antibiotics (ijab)]

How to cite this article:
Sudipta Roy. Antimicrobial Peptides and Bacteriophages as Next-Generation Alternatives to Conventional Antibiotics. International Journal of Antibiotics. 2024; 02(01):9-27.
How to cite this URL:
Sudipta Roy. Antimicrobial Peptides and Bacteriophages as Next-Generation Alternatives to Conventional Antibiotics. International Journal of Antibiotics. 2024; 02(01):9-27. Available from: https://journals.stmjournals.com/ijab/article=2024/view=188378


References

  1. Lemon DJ, Kay MK, Titus JK, Ford AA, Chen W, Hamlin NJ, Hwang YY. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018. J Microbiol. 2019 Jun;57(6):532-8.
  2. Kosikowska P, Lesner A. Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015). Expert Opin Ther Pat. 2016 Jun 2;26(6):689-702.
  3. Mandal SM, Roy A, Ghosh AK, Hazra TK, Basak A, Franco OL. Challenges and future prospects of antibiotic therapy: from peptides to phages utilization. Front Pharmacol. 2014 May 13;5:105.
  4. Lopes BS, Hanafiah A, Nachimuthu R, Muthupandian S, Md Nesran ZN, Patil S. The role of antimicrobial peptides as antimicrobial and antibiofilm agents in tackling the silent pandemic of antimicrobial resistance. Molecules. 2022 May 6;27(9):2995.
  5. Lopes BS, Hanafiah A, Nachimuthu R, Muthupandian S, Md Nesran ZN, Patil S. The role of antimicrobial peptides as antimicrobial and antibiofilm agents in tackling the silent pandemic of antimicrobial resistance. Molecules. 2022 May 6;27(9):2995.
  6. León-Buitimea A, Garza-Cárdenas CR, Garza-Cervantes JA, Lerma-Escalera JA, Morones-Ramírez JR. The demand for new antibiotics: antimicrobial peptides, nanoparticles, and combinatorial therapies as future strategies in antibacterial agent design. Front Microbiol. 2020 Jul 24;11:1669.
  7. Alaoui Mdarhri H, Benmessaoud R, Yacoubi H, Seffar L, Guennouni Assimi H, Hamam M, Boussettine R, Filali-Ansari N, Lahlou FA, Diawara I, Ennaji MM. Alternatives therapeutic approaches to conventional antibiotics: advantages, limitations and potential application in medicine. Antibiotics. 2022 Dec 16;11(12):1826.
  8. Chau T. Delivery, design, and mechanism of antimicrobial peptides. [dissertation]. Massachusetts Institute of Technology; 2014.
  9. Carmona-Ribeiro AM, Carrasco LD. Novel formulations for antimicrobial peptides. Int J Mol Sci. 2014 Oct 9;15(10):18040-83.
  10. Brandelli A. Nanostructures as promising tools for delivery of antimicrobial peptides. Mini Rev Med Chem. 2012 Jul 1;12(8):731-41.
Regular Issue Subscription Review Article
Volume 02
Issue 01
Received 25/11/2024
Accepted 03/12/2024
Published 07/12/2024
Views: 60